1 year return (CAGR)
25.48%
Olema Pharmaceuticals Inc Exchange (NASDAQ, USD)
OLMA
9.64
+0.17 (+1.75%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-6.13%
5 year return (CAGR)
-19.48%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
866.23M
Price/Sales
-
Ent value
873.64M
Price/Book
2.01
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-9.93%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 9.89 |
| Daily high | 10.35 |
| Daily low | 9.73 |
| Daily Volume | 927K |
| All-time high | 54.50 |
| 1y analyst estimate | 39.30 |
| Beta | 2.01 |
| EPS (TTM) | -1.96 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Mar 2026 |
Downside potential
Loading...
Downside potential data
| OLMA | S&P500 | |
| Current price drop from All-time high | -82.31% | -0.58% |
| Highest price drop | -96.26% | -56.47% |
| Date of highest drop | 11 May 2022 | 9 Mar 2009 |
| Avg drop from high | -75.17% | -10.68% |
| Avg time to new high | 366 days | 12 days |
| Max time to new high | 1455 days | 1805 days |
News
